Content related to Theranostics: Combining Cancer Therapeutics and Diagnostics

Microscopic image: MDM2 expression (in red) in retinoblastoma Rb176 cells. Credit: Donglai Qi, PhD, and David Cobrinik, MD, PhD. Researchers at The Saban Research Institute of Children’s Hospital Los

A new study from Children’s Hospital Los Angeles found that a specific pathway may be driving tumor growth in Ewing sarcoma.

Cultured retinoblastoma tumor containing tumor cells (red) and fibroblasts (green). Researchers at The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) have demonstrated that

Program combines clinical expertise and basic science to advance care in an understudied cancer.

Researchers use MRS imaging to study effects of hypothermia for infants with decreased oxygen to the brain.

With the addition of four scientists, the team is developing new and innovative approaches to CAR-T therapy in children.

Sarah Richman, MD, PhD Cancer and Blood Disease Institute Sarah Richman, MD, PhD, investigates the use of chimeric antigen receptor (CAR) T-cell therapy for solid tumors. She and others in the field